Syros Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 BDTX
|
Black Diamond Therapeutics, Inc. | $4.24 | $291.95 M | -3.13 | 54 | $0 |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.62 | $29.02 M | -0.46 | 100 | $7.88 M |
 CHRS
|
Coherus BioSciences, Inc. | $1.05 | $193.89 M | -2.28 | 246 | $257.24 M |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $50.71 | $3.53 B | -11.86 | 290 | $4.01 M |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 HARP
|
Harpoon Therapeutics, Inc. | $23.01 | $865.08 M | -15.04 | 45 | $31.92 M |
 IDYA
|
IDEAYA Biosciences, Inc. | $30.77 | $2.88 B | -19 | 124 | $23.39 M |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 KROS
|
Keros Therapeutics, Inc. | $56.50 | $1.76 B | -9.45 | 149 | $151,000 |
 KTTA
|
Pasithea Therapeutics Corp. | $6.07 | $5.84 M | -0.41 | 8 | $0 |
 KZR
|
Kezar Life Sciences, Inc. | $0.54 | $49.85 M | -0.49 | 58 | $7.00 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.58 | $611.84 M | -9.99 | 42 | $0 |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 PASG
|
Passage Bio, Inc. | $0.68 | $73.04 M | -0.77 | 58 | $0 |
 QNRX
|
Quoin Pharmaceuticals, Ltd. | $0.52 | $2.73 M | -0.11 | 4 | $0 |
 RGNX
|
REGENXBIO Inc. | $10.80 | $693.52 M | -2.4 | 344 | $90.24 M |
 RNXT
|
RenovoRx, Inc. | $1.05 | $24.43 M | -1.46 | 8 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.90 | $1.66 B | -6.02 | 184 | $0 |
 SPRO
|
Spero Therapeutics, Inc. | $1.30 | $75.85 M | 3.19 | 46 | $96.74 M |
 SRZN
|
Surrozen, Inc. | $10.25 | $35.47 M | -0.6 | 42 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $12.23 | $774.50 M | -6.14 | 110 | $8.78 M |
 XNCR
|
Xencor, Inc. | $20.26 | $1.34 B | -10.02 | 280 | $168.34 M |